Published in Women's Health Weekly, January 26th, 2006
In a recently published article, scientists in the United States conducted a study "[t]o determine if fetal fibronectin can be used in a clinical setting to predict preterm birth and guide clinical management."
"We implemented a clinical protocol using the rapid fetal fibronectin test for patients presenting with symptoms Of preterm labor. Adherence to the clinical pathway was at the discretion of the practitioner," wrote G.K. Swamy and colleagues, Duke University.
The authors explained, "Subjects who met the inclusion criteria (n=404) were divided into 2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly